Meningococcal Group B Vaccine (Bexsero)
Meningococcal Group B Vaccine is an FDA-licensed reference biologic from GlaxoSmithKline Biologicals. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
2015
Reference approved
Reference product
Bexsero Meningococcal Group B Vaccine
GlaxoSmithKline Biologicals
- Approved
- Jan 23, 2015
- Marketing
- Rx
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for Meningococcal Group B Vaccine, in chronological order.
Reference approval
Approval date of the reference Meningococcal Group B Vaccine product.
11 yr 6 mo ago
Frequently asked questions
Are there biosimilars approved for Meningococcal Group B Vaccine (Bexsero)?
No 351(k) biosimilars or interchangeable biosimilars referencing Meningococcal Group B Vaccine are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.